Skip to main navigation Skip to search Skip to main content

Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the PARMA trial.

Translated title of the contribution: Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the PARMA trial.
  • C. Guglielmi
  • , F. Gomez
  • , T. Philip
  • , A. Hagenbeek
  • , M. Martelli
  • , C. Sebban
  • , N. Milpied
  • , D. Bron
  • , J.Y. Cahn
  • , R. Somers
  • , P. Sonneveld
  • , C. Gisselbrecht
  • , H. van der Lelie
  • , F. Chauvin

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionTime to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the PARMA trial.
Original languageUndefined/Unknown
Pages (from-to)3264-3269
Number of pages6
JournalJournal of Clinical Oncology
Volume16
Publication statusPublished - 1998

Cite this